Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Magali Michaut

3PUBLICATIONS
28CO-AUTHORS
Molecular medicinePredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jan 28, 2022
Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists.

Vera Grinkevitch, Mark Wappett, Nyree Crawford

|Dec 08, 2018
Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, <i>BRCA1</i>-like status, tumor-infiltrating immune cells and survival.

Marcelo Sobral-Leite, Koen Van de Vijver, Magali Michaut

|Jan 19, 2018
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells.

Krishna Kalyan Kolluri, Constantine Alifrangis, Neelam Kumar

Pageof 1

Frequent Collaborators

1 joint publications

Krishna Kalyan Kolluri

1 joint publications

Constantine Alifrangis

1 joint publications

Neelam Kumar

1 joint publications

Steven Williams

1 joint publications

Elizabeth K Sage

1 joint publications

Samuel M Janes

1 joint publications

Marcelo Sobral-Leite

1 joint publications

Koen Van de Vijver

1 joint publications

Hugo M Horlings

1 joint publications

Tesa M Severson

Frequent Collaborators

1 joint publications

Krishna Kalyan Kolluri

1 joint publications

Constantine Alifrangis

1 joint publications

Neelam Kumar

1 joint publications

Steven Williams

Top Related Videos

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on : Dec 09, 2015

10.7K
Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on : Sep 25, 2018

11.0K
Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
08:07

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on : Nov 23, 2019

11.9K
See more related videos

Top Related Videos

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on : Dec 09, 2015

10.7K
Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on : Sep 25, 2018

11.0K
Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
08:07

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on : Nov 23, 2019

11.9K
See more related videos